ArticleNews reportPHN-05652026-11-02 04:51 CT

Sun Pharma Gets Approval For Semaglutide Pill In India: How Will This Impact Diabetes Treatment?

Source · NDTV

TLDR

NDTV reports that Sun Pharma received approval from India's Central Drugs Standard Control Organisation to manufacture and market generic oral semaglutide for Type 2 diabetes. The approval expands the company's oral and injectable GLP-1 portfolio; its retail price has not been announced.

01—Key points

01The article describes the tablet as therapeutically equivalent to Novo Nordisk's Rybelsus.
02Sun Pharma joins existing Indian generic oral semaglutide makers Torrent Pharma and Dr. Reddy's Laboratories.
03Sun Pharma previously launched injectable semaglutide products for Type 2 diabetes and chronic weight management.

Why it matters Editorial

The approval adds another competitor to India's generic oral semaglutide market, which the article says could improve affordability through price competition.

Read the original at NDTV↗

Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.